Postdoctoral Fellow in Molecular Mechanisms of Neurodegeneration (Neuroscience, Bingol Lab) Genentech in United States

The Bingol Lab at Genentech is recruiting Postdoctoral Fellows to advance neurodegeneration target discovery, focusing on the molecular mechanisms underlying lysosomal and mitochondrial quality control in diseases such as Alzheimer’s, Parkinson’s, and ALS. This high-impact research opportunity leverages state-of-the-art technologies including proteomics, iPSC models, CRISPR, and AI/ML-supported computational biology to investigate how human genetic variants disrupt organelle and protein quality pathways. The lab is led by Baris Bingol, Senior Director and Distinguished Scientist at Genentech, a renowned biotechnology company based in South San Francisco, California.

Applicants should possess a PhD in Molecular or Cellular Neuroscience or a related field, with at least 4 years of expertise in mechanistic research. Experience with iPSC-based CNS cell models, primary rodent cultures, genetic perturbations, and organelle biology is required. Candidates must demonstrate a strong drive to understand disease mechanisms, thrive in collaborative environments, and possess outstanding communication skills. A robust publication record in mechanistic molecular and cellular neurobiology is highly desirable.

Genentech is a member of the Roche group and a pioneer in biotechnology, with a commitment to groundbreaking science and therapeutic discovery. The Bingol Lab offers a collaborative and innovative research environment, providing opportunities for first-author publications and direct contributions to breakthrough therapeutic discoveries. While specific funding details are not provided, the position is a postdoctoral fellowship at a leading industry institution.

To apply, candidates should visit the Genentech careers portal and submit their application through the official job posting. Additional information and updates can be accessed by joining the Genentech talent network. This position is ideal for independent scientists eager to make a significant impact in neurodegeneration research.